Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients. - Wikidata - wikimedia - TriplyDB

Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.

Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.

http://www.wikidata.org/entity/Q37402417

about

Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.

http://www.wikidata.org/entity/Q37402417

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.

@en

Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.

@nl

type

label

Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.

@en

Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.

@nl

prefLabel

Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.

@en

Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.

@nl

P1433

Q37402417-F2560D68-B581-4DB2-A49D-AD6696E3EEEA

P1476

Q37402417-202C5ECF-BB27-4D18-AA41-1BD5DC1E4D63

P2093

Q37402417-139D3C1E-4325-465B-856B-9C9FBEEEAFCC

Q37402417-5583D0AC-95B9-4140-8C2F-7AF33DC826F5

Q37402417-5F92A2FC-1D24-4A00-B850-7EF6E506E32A

Q37402417-6A7150A1-C7F7-4B82-BEEF-4B941BF6DBE2

Q37402417-77332DF3-1A1E-4752-8344-52751D13DE29

Q37402417-7BEB1D7C-3EDE-4DDC-88B6-790F67D96B74

Q37402417-9C70C566-1280-4BA5-94E5-977B38FA0EE9

Q37402417-BCC61013-1DA0-4D98-A187-F28B6F3B655F

Q37402417-E51293BD-3F9C-4708-B156-BF882D05FB03

P2860

Q37402417-0312F500-9726-44A2-8C04-2AD80153F26E

Q37402417-03AF7BA5-9E4B-4618-B925-A487295B18DE

Q37402417-042FDB29-0D3F-447B-A5D7-09495CD664E6

Q37402417-0909D9EE-66DB-407E-A199-BEFF73CB776F

Q37402417-0A85F137-511C-491E-A3B3-62CDA0466196

Q37402417-15500EE6-8EF3-4631-9954-4F4A2E986404

Q37402417-21CC7BA1-BD33-4D5A-B6FE-591803ABE411

Q37402417-27195147-B588-41C8-AEEB-4E39AA92150E

Q37402417-2736DD28-DAB0-4545-9DDA-AAFB2FCAFFC4

Q37402417-45B0480A-F9A1-481C-9A8D-A9A99C1217E2

P304

Q37402417-4D784FE7-0EB0-4C37-B6B2-5713A4515BD8

P31

Q37402417-8CFD3F4B-99A6-4AB9-A034-0A2D469A8197

P356

Q37402417-C80BE05E-4680-4992-9AD4-C47C88289EFD

P433

Q37402417-0C54F99C-9880-4485-B8F4-4AB292B916B8

P478

Q37402417-00AF84C3-01C0-4D91-8F35-C1A913DCC6FC

P577

Q37402417-6E8912D0-5E75-4169-80B9-8A3849722580

P698

Q37402417-4494E535-3C0A-4DB7-8B16-357E20050AFB

P921

Q37402417-EB4519D8-3444-485E-8ECE-84DA9A5BF6AF

P932

Q37402417-4FE894E1-905F-4ADD-9F38-9DECC60B01E4

P356

P1433

Cardiovascular Journal of Africa

P1476

Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.

@en

P2093

Ahmet Senol Uyar

http://www.w3.org/2001/XMLSchema#string

Emre Tutal

http://www.w3.org/2001/XMLSchema#string

Mehtap Erkmen Uyar

http://www.w3.org/2001/XMLSchema#string

Piril Yucel

http://www.w3.org/2001/XMLSchema#string

Saliha Yildirim

http://www.w3.org/2001/XMLSchema#string

Sena Ilin

http://www.w3.org/2001/XMLSchema#string

Siren Sezer

http://www.w3.org/2001/XMLSchema#string

Tankut Akay

http://www.w3.org/2001/XMLSchema#string

Zeynep Bal

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiovascular disease and the kidney: an epidemiologic overview.

Use of prostacyclin and its analogues in the treatment of cardiovascular disease.

Microvascular endothelial injury and dysfunction during ischemic acute renal failure.

Influence of fluid resuscitation on renal microvascular PO2 in a normotensive rat model of endotoxemia.

Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment.

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.

Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

The confounding issue of comorbid renal insufficiency.

Normotensive ischemic acute renal failure.

Acute cardio-renal syndrome: progression from congestive heart failure to congestive kidney failure.

P304

128-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5830/CVJA-2015-051

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27841898

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

5101430

http://www.w3.org/2001/XMLSchema#string